David Gionco, Chief Accounting Officer at STEMLINE THERAPEUTICS INC (STML), sold 13,857 shares at $4.92 ($69K) on 2020-03-10, disclosed to the SEC on 2020-03-13.
Seasonal sale ($69k) by Chief Accounting Officer — this insider has traded STML in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.08 | 5,011 | $25K | 36.9% |
| 2 | $4.92 | 8,846 | $44K | 63.1% |
| Total | $4.98 avg | 13,857 | $69K | 100% |
| Filing → |
| STML | SELL | 2020-02-28 | $118K | — | Filing → |
| STML | SELL | 2020-01-03 | $49K | — | Filing → |
| STML | SELL | 2019-03-15 | $306K | — | Filing → |